Clinical Trial: A First-in-Human Study to Evaluate JCXH-105, an srRNA-based Herpes Zoster Vaccine
Study Status: ACTIVE_NOT_RECRUITING
Recruit Status: ACTIVE_NOT_RECRUITING
Condition: Herpes Zoster (HZ)
Study Type: INTERVENTIONAL
Official Title: A Phase 1 Randomized, Double-Blinded, Active-Controlled, 2-Dose Study to Assess the Safety and Immunogenicity of a Herpes Zoster (HZ) Vaccine, JCXH-105, in Healthy Subjects 50 to 69 Years of Age.
Brief Summary:
The goal of this clinical trial is to assess the safety and immunogenicity of a self-replicating (sr) RNA-based vaccine, JCXH-105, in the prevention of Shingles (Herpes Zoster)Participant will be randomized to receive either JCXH-105 or Shingrix.
Read more